Pacer Advisors
CNMD icon

Pacer Advisors’s CONMED CNMD Stock Holding History

Pacer Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-158,773
Closed -$5.61M – 2579
2026
Q1 		$5.61M Buy
158,773
+15,765
+11% +$641K 0.02% 587
2025
Q4 		$5.81M Buy
+143,008
New +$6.22M 0.01% 637
2025
Q3 		– Sell
-1,683
Closed -$87.7K – 3923
2025
Q2 		$87.7K Buy
+1,683
New +$92.4K ﹤0.01% 2604
2025
Q1 		– Sell
-1,656
Closed -$113K – 3670
2024
Q4 		$113K Buy
1,656
+485
+41% +$33.8K ﹤0.01% 2526
2024
Q3 		$84.2K Buy
1,171
+669
+133% +$47.2K ﹤0.01% 2029
2024
Q2 		$34.8K Buy
+502
New +$36.6K ﹤0.01% 3307

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Pacer Advisors's CNMD Position: Q2 2026 in Review

Pacer Advisors sold out of CONMED (CNMD) in Q2 2026, closing a stake of 158,773 shares — an estimated $5.61M sold.

Pacer Advisors first reported a position in CNMD in Q2 2024 and held it in 6 quarters. The position peaked at $5.81M in Q4 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Pacer Advisors reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • Pacer Advisors sold 158,773 CONMED shares in Q2 2026, an estimated $5.61M.
  • Pacer Advisors first reported a position in CONMED in Q2 2024 and held it in 6 quarters.
  • Pacer Advisors's CONMED position peaked at $5.81M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.